|

Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs

RECRUITINGSponsored by Institut Rafael
Actively Recruiting
SponsorInstitut Rafael
Started2024-03-08
Est. completion2027-03-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06317714

Summary

Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age equal to or greater than 18 years (adult)
* Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix)
* Patients benefiting from non-pharmacological treatment at the Rafael Institute
* Who understands the French language

Exclusion Criteria:

* \< 18 years old
* Patient deprived of liberty, under guardianship or unable to give consent

Conditions4

CancerOncologyQuality of LifeSymptoms and Signs

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.